⌘K

Login Start Free

Home/Filings/4/0001968202-24-000079

4//SEC Filing

SING GEORGE L 4

Accession 0001968202-24-000079

CIK 0000872589other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 4:04 PM ET

Size

12.8 KB

Accession

0001968202-24-000079

Insider Transaction Report

Form 4

Period: 2024-02-26

REGENERON PHARMACEUTICALS, INC.REGN

Director

Transactions

Exercise/Conversion
Common Stock
2024-02-26$413.33/sh+500$206,665→ 26,849 total
Sale
Common Stock
2024-02-26$990.00/sh−500$495,000→ 26,349 total
Exercise/Conversion
Common Stock
2024-02-26$413.33/sh+500$206,665→ 26,849 total
Sale
Common Stock
2024-02-26$995.00/sh−500$497,500→ 26,349 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-02-26−1,000→ 5,338 total
Exercise: $413.33Exp: 2025-01-02→ Common Stock (1,000 underlying)

Holdings

Common Stock
(indirect: By Spouse)
750
Common Stock
(indirect: By Spouse)
400
Common Stock
(indirect: By Trust)
1,000

Footnotes (1)

[F1]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

REGENERON PHARMACEUTICALS, INC.

CIK 0000872589

Entity typeother

Related Parties

1

filerCIK 0001225471

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 4:04 PM ET
Size: 12.8 KB

View on SEC.gov